Factor | Fraqueza2014 (10189)

Production system

Chicken | Carcass

11

Description

Extensive indoor vs intensive.

Resistance Outcomes

Resistance Microbe Outcome
Ampicillin
/
Campylobacter Not Specified
See: Table 5 AMR+ (%) AMR- (%) Total (n)
Extensive indoor 74.80 100
Intensive 72.90 100
Amoxicillin And Beta-Lactamase Inhibitor
/
Campylobacter Not Specified
See: Table 5 AMR+ (%) AMR- (%) Total (n)
Extensive indoor 56.70 100
Intensive 2.70 100
Ciprofloxacin
/
Campylobacter Not Specified
See: Table 5 AMR+ (%) AMR- (%) Total (n)
Extensive indoor 77.40 100
Intensive 96.40 100
Norfloxacin
/
Campylobacter Not Specified
See: Table 5 AMR+ (%) AMR- (%) Total (n)
Extensive indoor 74.00 100
Intensive 95.90 100
Ofloxacin
/
Campylobacter Not Specified
See: Table 5 AMR+ (%) AMR- (%) Total (n)
Extensive indoor 58.30 100
Intensive 95.40 100
Nalidixic Acid
/
Campylobacter Not Specified
See: Table 5 AMR+ (%) AMR- (%) Total (n)
Extensive indoor 87.70 100
Intensive 97.90 100
Erythromycin
/
Campylobacter Not Specified
See: Table 5 AMR+ (%) AMR- (%) Total (n)
Extensive indoor 16.20 100
Intensive 25.60 100
Tetracycline
/
Campylobacter Not Specified
See: Table 5 AMR+ (%) AMR- (%) Total (n)
Extensive indoor 40.80 100
Intensive 82.90 100
Sulfamethoxazole And Trimethoprim
/
Campylobacter Not Specified
See: Table 5 AMR+ (%) AMR- (%) Total (n)
Extensive indoor 48.00 100
Intensive 48.60 100
Chloramphenicol
/
Campylobacter Not Specified
See: Table 5 AMR+ (%) AMR- (%) Total (n)
Extensive indoor 7.10 100
Intensive 0.80 100
Gentamicin
/
Campylobacter Not Specified
See: Table 5 AMR+ (%) AMR- (%) Total (n)
Extensive indoor 44.20 100
Intensive 0.80 100